AU501298B1 - Semisynthetic 4, erythromycin a derivatives - Google Patents

Semisynthetic 4, erythromycin a derivatives

Info

Publication number
AU501298B1
AU501298B1 AU32990/78A AU3299078A AU501298B1 AU 501298 B1 AU501298 B1 AU 501298B1 AU 32990/78 A AU32990/78 A AU 32990/78A AU 3299078 A AU3299078 A AU 3299078A AU 501298 B1 AU501298 B1 AU 501298B1
Authority
AU
Australia
Prior art keywords
semisynthetic
erythromycin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU32990/78A
Other languages
English (en)
Inventor
F. O Sciavolino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/856,479 external-priority patent/US4150220A/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of AU501298B1 publication Critical patent/AU501298B1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU32990/78A 1977-02-04 1978-02-03 Semisynthetic 4, erythromycin a derivatives Expired AU501298B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US76548077A 1977-02-04 1977-02-04
USUS765480 1977-02-04
USUS856479 1977-12-01
US05/856,479 US4150220A (en) 1977-02-04 1977-12-01 Semi-synthetic 4"-erythromycin A derivatives

Publications (1)

Publication Number Publication Date
AU501298B1 true AU501298B1 (en) 1979-06-14

Family

ID=27117613

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32990/78A Expired AU501298B1 (en) 1977-02-04 1978-02-03 Semisynthetic 4, erythromycin a derivatives

Country Status (30)

Country Link
JP (1) JPS5827798B2 (zh)
AR (1) AR222147A1 (zh)
AU (1) AU501298B1 (zh)
BG (2) BG32718A3 (zh)
CA (1) CA1106367A (zh)
CH (1) CH628906A5 (zh)
CS (1) CS221801B2 (zh)
DD (1) DD140048A5 (zh)
DE (1) DE2804507C2 (zh)
DK (1) DK148036C (zh)
ES (2) ES466057A1 (zh)
FI (1) FI780354A (zh)
FR (2) FR2379550A1 (zh)
GB (2) GB1585316A (zh)
GR (1) GR68691B (zh)
HU (1) HU182559B (zh)
IE (1) IE46661B1 (zh)
IL (2) IL53968A0 (zh)
IT (1) IT1094209B (zh)
LU (1) LU79004A1 (zh)
NL (1) NL176174C (zh)
NO (2) NO146472C (zh)
NZ (1) NZ186385A (zh)
PH (2) PH14421A (zh)
PL (1) PL116228B1 (zh)
PT (1) PT67568B (zh)
RO (4) RO77345A (zh)
SE (2) SE445223B (zh)
SU (1) SU927122A3 (zh)
YU (3) YU40913B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4124755A (en) * 1978-01-03 1978-11-07 Pfizer Inc. 11-Alkanoyl-4"-deoxy-4"-isonitrilo-oleandomycin derivatives
US4133950A (en) * 1978-01-03 1979-01-09 Pfizer Inc. 4"-Deoxy-4"-carbamate and dithiocarbamate derivatives of oleandomycin and its esters
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6407074B1 (en) 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836519A (en) * 1973-05-04 1974-09-17 Abbott Lab Sulfonyl derivatives of erythromycin
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives

Also Published As

Publication number Publication date
FR2385735B1 (zh) 1980-10-24
GR68691B (zh) 1982-02-01
FR2385735A1 (fr) 1978-10-27
NO146472B (no) 1982-06-28
RO81622A (ro) 1983-04-29
HU182559B (en) 1984-02-28
IT7820005A0 (it) 1978-02-03
ES472429A1 (es) 1979-04-01
YU40799B (en) 1986-06-30
DK51878A (da) 1978-08-05
PH14421A (en) 1981-07-10
NL176174B (nl) 1984-10-01
NO150484C (no) 1984-10-24
IL53968A0 (en) 1978-04-30
SE8300870L (sv) 1983-02-16
PT67568B (en) 1979-06-18
RO79687A7 (ro) 1982-08-17
SE445223B (sv) 1986-06-09
GB1585315A (en) 1981-02-25
IE780239L (en) 1978-08-04
RO81622B (ro) 1983-04-30
NL176174C (nl) 1985-03-01
PT67568A (en) 1978-02-01
BG33159A3 (en) 1982-12-15
YU227983A (en) 1984-04-30
IL61997A0 (en) 1981-02-27
SE457086B (sv) 1988-11-28
CS221801B2 (en) 1983-04-29
FR2379550A1 (fr) 1978-09-01
LU79004A1 (fr) 1979-09-06
YU40798B (en) 1986-06-30
PL204428A1 (pl) 1979-06-04
RO79686A7 (ro) 1982-08-17
YU40913B (en) 1986-08-31
ES466057A1 (es) 1978-10-01
FR2379550B1 (zh) 1980-07-04
IE46661B1 (en) 1983-08-24
CA1106367A (en) 1981-08-04
BG32718A3 (en) 1982-09-15
SE8300870D0 (sv) 1983-02-16
CH628906A5 (en) 1982-03-31
NO150484B (no) 1984-07-16
NO780389L (no) 1978-08-07
YU7378A (en) 1983-04-30
FI780354A (fi) 1978-08-05
DE2804507C2 (de) 1982-11-04
YU26583A (en) 1984-02-29
DD140048A5 (de) 1980-02-06
DE2804507A1 (de) 1978-08-10
GB1585316A (en) 1981-02-25
NO146472C (no) 1982-10-06
RO77345A (ro) 1981-08-17
DK148036C (da) 1985-07-15
NL7801262A (nl) 1978-08-08
DK148036B (da) 1985-02-11
SU927122A3 (ru) 1982-05-07
PL116228B1 (en) 1981-05-30
SE7800270L (sv) 1978-08-05
PH16675A (en) 1983-12-13
NO811913L (no) 1978-08-07
AR222147A1 (es) 1981-04-30
NZ186385A (en) 1980-10-08
IT1094209B (it) 1985-07-26
JPS5827798B2 (ja) 1983-06-11
JPS53101337A (en) 1978-09-04

Similar Documents

Publication Publication Date Title
AU522538B2 (en) 1, 2-benzothiazine-1, 1-dioxide derivatives
AU3921478A (en) 3,4,5 trihydroxypiperidine derivatives
JPS5476588A (en) Erythromycin derivative
AU509680B2 (en) 1,9-dihydroxyoctahydrophenanthrenes
AU521102B2 (en) 2, 6-diaminonebularines
AU514452B2 (en) 3, 3, 3-triarylalkyl-4-phenylalkl-4-hydroxy piperidine derivatives
AU513688B2 (en) 1, l-disubstituted-3-heterocyclo urea derivatives
AU501298B1 (en) Semisynthetic 4, erythromycin a derivatives
AU526584B2 (en) 2,3-dicyanopyrazine derivatives
AU515506B2 (en) 1, 2, 4-oxadiazole derivatives
AU517160B2 (en) Dibenzo(d,g) (1,3,6)dioxazocine derivatives
AU515140B2 (en) 2, 4, 7-triamino-pteridine derivatives
AU527943B2 (en) 2, 4-diamino-5-benzylpyrimidines
GB2091266B (en) 16,17-pyrazolino-and 16,17-isopyrazolino-1,4-pregnadiene derivatives
AU527026B2 (en) Fortimicin a derivatives
GB2017104B (en) 4-thia-2,6-diaza-bicyclo-(3,2,0-)-heptane derivatives
AU518208B2 (en) 2,4-dichlorophenyl-triazolyl-ethan-one and -ol derivatives
AU3347778A (en) 1,2,4,-benzotriazine-di-n-oxide derivatives
AU505664B2 (en) 2, 1, 3-benzothiadiazoles
AU518292B2 (en) 1,4-benzoxathin-2-carboxamides
AU516080B2 (en) 1, 2, 3-thiadiazolin-2-ide derivatives
AU519623B2 (en) Pyrand [4,3-e]-as-triazines
AU516608B2 (en) Phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine-7-8-dione derivatives
AU492706B2 (en) Semisynthetic oleandomycins
AU509734B2 (en) Amino-substituted hexahydro-pyridino( 1, 2-d)-dibenzo ( b,f) (1, 4) -diazepino derivatives